532067 logo

3B Blackbio Dx Limited Stock Price

BSE:532067 Community·₹10.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

532067 Share Price Performance

₹1,259.00
-675.25 (-34.91%)
₹1,259.00
-675.25 (-34.91%)
Price ₹1,259.00

532067 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
2 Rewards

3B Blackbio Dx Limited Key Details

₹1.0b

Revenue

₹285.7m

Cost of Revenue

₹754.6m

Gross Profit

₹262.4m

Other Expenses

₹492.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
57.44
72.54%
47.31%
0.09%
View Full Analysis

About 532067

Founded
1972
Employees
85
CEO
Dhirendra Dubey
WebsiteView website
3bblackbio.com

3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.

Recent 532067 News & Updates

Recent updates

No updates